# ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial

> **NCT04742205** · PHASE2,PHASE3 · COMPLETED · sponsor: **Kathmandu Medical College and Teaching Hospital** · enrollment: 154 (actual)

## Conditions studied

- Cerebral Hemorrhage

## Interventions

- **DRUG:** Tranexamic Acid 500 MG

## Key facts

- **NCT ID:** NCT04742205
- **Lead sponsor:** Kathmandu Medical College and Teaching Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-08
- **Primary completion:** 2023-12-05
- **Final completion:** 2024-06-04
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04742205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04742205, "ITCH Trial: Protocol for a Randomized, Double Blind Placebo-controlled Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04742205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*